Pioglitazone HCL and Metformin HCL 500 mg/1

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets are a combination medication used to manage type 2 diabetes. This oral medication helps control blood sugar levels and improve insulin sensitivity.

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets are commonly used to manage type 2 diabetes. This combination medication works by improving insulin sensitivity and reducing blood sugar levels. It is often prescribed for individuals who require dual therapy to control their diabetes effectively. The primary use of this medication is to help manage blood glucose levels in adults with type 2 diabetes.

Common effects of Pioglitazone HCL and Metformin HCL 500 mg/1 tablets may include mild gastrointestinal discomfort, weight gain, and occasional dizziness. Some individuals may experience fluid retention or low blood sugar levels, especially when starting the medication. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets should be used with caution in individuals with a history of heart disease, liver issues, or kidney problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular monitoring of blood sugar levels and periodic medical check-ups are recommended while using this medication.

Pioglitazone HCL and Metformin HCL 500 mg/1 tablets may interact with certain medications, including other diabetes drugs, insulin, and some antibiotics. Alcohol consumption should be avoided as it can increase the risk of low blood sugar levels. It is important to inform your healthcare provider about all medications and supplements you are taking to avoid potential interactions.